ArticleNanomedicine (London, England)2019
Calcium carbonate nanoparticles stimulate tumor metabolic reprogramming and modulate tumor metastasis.
Abstract read
In one paragraph
Article in Nanomedicine (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 35 citations in OpenAlex.
- Hypoxia-specific metal-organic frameworks combined with lactate immunometabolism regulation augment anti-tumor immunity of HIFU.Materials today. Bio · 2026Article
- For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy.Materials today. Bio · 2025Review
- Biochemical hallmarks-targeting antineoplastic nanotherapeutics.Bioactive materials · 2024Review
- Amorphous Calcium Carbonate Shows Anti-Cancer Properties That are Attributed to Its Buffering Capacity.Cancers · 2023Article
- Calcium carbonate vaterite particles for drug delivery: Advances and challenges.Materials today. Advances · 2022Review
- Tumor Microenvironment Modulating Functional Nanoparticles for Effective Cancer Treatments.Tissue engineering and regenerative medicine · 2022Review
- Development of a Nanoscale Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Contrast Agent That Measures pH.ACS nano · 2021Article
- Simultaneous Evaluations of pH and Enzyme Activity with a CEST MRI Contrast Agent.ACS sensors · 2021Article
- Insight into the Technical Qualification of the Sonocogreen CaO/Clinoptilolite Nanocomposite (CaOACS omega · 2021Article
- Key Points in Remote-Controlled Drug Delivery: From the Carrier Design to Clinical Trials.International journal of molecular sciences · 2021Review
- Synthesis and Characterization of Gefitinib and Paclitaxel Mono and Dual Drug-Loaded Blood Cockle Shells (Nanomaterials (Basel, Switzerland) · 2021Article
- The reversed intra- and extracellular pH in tumors as a unified strategy to chemotherapeutic delivery using targeted nanocarriers.Acta pharmaceutica Sinica. B · 2021Review
- Transforming Cancer Nanotechnology Data Analysis and User Experience. Part I: Current Challenges and Solutions Provided by caNanoLab.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 4 institutions in 1 country.
Avik SomMallinckrodt Institute of Radiology, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
Ramesh RaliyaDepartment of Energy, Environmental, Chemical Engineering, Washington University in St Louis, St Louis, MO 63130, USA.
Krishna ParanandiMallinckrodt Institute of Radiology, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
Rachel A HighCancer Biology Graduate Interdisciplinary Program, University of Arizona Cancer Center, Tucson, AZ 54724, USA.
Nathan ReedDepartment of Energy, Environmental, Chemical Engineering, Washington University in St Louis, St Louis, MO 63130, USA.
Scott C BeemanMallinckrodt Institute of Radiology, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
Matthew BrandenburgMallinckrodt Institute of Radiology, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
Gail SudlowMallinckrodt Institute of Radiology, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
Julie L PriorMallinckrodt Institute of Radiology, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
Walter AkersMallinckrodt Institute of Radiology, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
Annelise Y Mah-SomCenter for In Vivo Imaging & Therapeutics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Lemoyne Habimana-GriffinMallinckrodt Institute of Radiology, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
Joel GarbowMallinckrodt Institute of Radiology, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
Joseph E IppolitoMallinckrodt Institute of Radiology, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
Mark D PagelCancer Biology Graduate Interdisciplinary Program, University of Arizona Cancer Center, Tucson, AZ 54724, USA.
Pratim BiswasDepartment of Energy, Environmental, Chemical Engineering, Washington University in St Louis, St Louis, MO 63130, USA.
Samuel AchilefuMallinckrodt Institute of Radiology, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
Mallinckrodt (United States) · USWashington University in St. Louis · USUniversity of Arizona Cancer CenterSt. Jude Children's Research Hospital · US
Funding
Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0MNATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTISTT32GM007200 · NIGMS · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 1985 to 2024
$59.8MWU-MDACC Inter-Institutional Molecular Imaging CenterP50CA094056 · NCI · WASHINGTON UNIVERSITY · PI KOPAN, RAPHAEL · 2002 to 2016
$26.3MProject 2 - Radiation-Induced Treatment of Multiple Myeloma using NanoparticlesU54CA199092 · NCI · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2015 to 2019
$11.5MDEVELOPMENT OF GOGGLE SYSTEM FOR FLUORESCENCE IMAGE-GUIDED SURGERYR01CA171651 · NCI · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2013 to 2017
$2.8MNANOPHOTOSENSITIZERS FOR REGENERATIVE PHOTOTHERAPY OF TUMORSR01EB021048 · NIBIB · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2015 to 2020
$2.3MMULTIMODAL PRECLINICAL CANCER IMAGING AND THERAPY RESEARCH SPECIALISTR50CA211481 · NCI · WASHINGTON UNIVERSITY · PI AKERS, WALTER JOHN · 2016 to 2020
$841kMR ADIPOSE-O2 QUANTIFICATION AND THE HYPOXIA-DRIVEN INSULIN RESISTANCE HYPOTHESISK01DK109119 · NIDDK · WASHINGTON UNIVERSITY · PI BEEMAN, SCOTT CHARLES · 2016 to 2020
$652kFLUORESCENCE MOLECULAR TOMOGRAPHY SYSTEMS10OD020129 · OD · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2015 to 2015
$330kFLUORESCENCE LIFETIME IMAGING MICROSCOPY SYSTEMS10OD016237 · OD · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2014 to 2014
$267kIVIS LUMINA II XR FOR OPTICAL IMAGING OF RADIOPHARMACEUTICALSS10RR031625 · NCRR · WASHINGTON UNIVERSITY · PI TAI, YUAN-CHUAN · 2011 to 2011
$218kA NOVEL EXTRACELLULAR AND INTRACELLULAR TREATMENT PARADIGM FOR ERADICATING CANCERF30CA189435 · NCI · WASHINGTON UNIVERSITY · PI SOM, AVIK · 2014 to 2017
$135kNCI NIH HHS F30 CA189435NCI NIH HHS P30 CA091842NCI NIH HHS P50 CA094056NCI NIH HHS R01 CA171651NCI NIH HHS R50 CA211481NCI NIH HHS U54 CA199092NCRR NIH HHS S10 RR031625NIAID NIH HHS F30 AI129110NIBIB NIH HHS R01 EB021048NIDDK NIH HHS K01 DK109119NIGMS NIH HHS T32 GM007200NIH HHS S10 OD016237NIH HHS S10 OD020129
Abstract
aimCaCO MATERIALS &
methodsWe synthesized ferromagnetic core coated with CaCO
resultsMagnetite CaCO
conclusionNano-CaCO
Indexed as
Calcium CarbonateAnimalsBreast NeoplasmsCell Line, TumorCell SurvivalFemaleFibrosarcomaHumansMaleMiceNanoparticlesNeoplasm MetastasisParticle SizeTheranostic NanomedicineTumor MicroenvironmentCalcium CarbonatemagnetiteMRInano-CaCOpH modulationtheranostic
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.